Status:
TERMINATED
Fluvoxamine Maleate in the Treatment of Obsessive-Compulsive Disorder: A Post-marketing Clinical Study in Children and Adolescents
Lead Sponsor:
Solvay Pharmaceuticals
Conditions:
Obsessive Compulsive Disorder
Eligibility:
All Genders
8-18 years
Phase:
PHASE4
Brief Summary
This study is to verify the efficacy of fluvoxamine maleate given for 10 weeks in treatment of children and adolescents with obsessive-compulsive disorder
Eligibility Criteria
Inclusion
- Inclusion Criteria Have a minimum total score of 16 on the JCY-BOCS, Weight is within the standard weight ± 2S.D. based on the standard weight for each age in the School Health Statistical Survey Exclusion Criteria Have the following predominant psychiatric diagnosis -Schizophrenia Have previously been treated with fluvoxamine maleate
Exclusion
Key Trial Info
Start Date :
August 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2009
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00352768
Start Date
August 1 2006
End Date
April 1 2009
Last Update
March 4 2010
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
S114.3.118 Kohnodai Hospital, National Center of N
Chiba Prefecture, Japan
2
S114.3.118 Kyushu University Hospital
Fukuoka Prefecture, Japan
3
S114.3.118 Hiroshima-city Funairi Hospital
Hiroshima Prefecture, Japan
4
S114.3.118 Goryokai Hospital
Hokkaido Prefecture, Japan